Retatrutide and tirzepatide both target hormones involved in appetite and blood sugar control, but there are key differences
This hormone plays a key role in regulating blood sugar levels, slowing digestion, and helping you feel full after eating
Cardiovascular outcome trials in patients with T2D have demonstrated the efficacy of GLP-1 RAs in reducing major adverse cardiovascular events, including cardiovascular death, MI and stroke, regardless of glycaemic control
Retatrutide 50MG is of interest to researchers working on peptide hormone analog design, receptor selectivity, and metabolic disease models where GLP-1, GIP, and glucagon pathways are commonly evaluated
Biochim Biophys Acta 1146 : 229235 Aureli T, Miccheli A, Ricciolini R, Di Cocco ME, Ramacci MT, Angelucci L, Ghirardi O, Conti F